Author | Lee S. Schwartzberg, MD, FACP | OncLive

Author | Lee S. Schwartzberg, MD, FACP

Articles

Dr. Schwartzberg on Increasing Competition With Biosimilars in Oncology

November 14, 2019

Video

Lee S. Schwartzberg, MD, FACP, explains how biosimilars could lead to increased competition in oncology.

Dr. Schwartzberg on the Use of Therapeutic Biosimilars in Breast Cancer

November 07, 2019

Video

Lee S. Schwartzberg, MD, FACP, chief medical officer, OneOncology, chief and professor of medicine, Division of Hematology/Oncology, the University of Tennessee Health Science Center, medical director, West Clinic, and executive director, West Cancer Center, discusses the use of therapeutic biosimilars in breast cancer.

Effective Management of CINV Improves Response to Treatment

January 26, 2018

Article

The goal of selecting optimal antiemetic therapy continues to be a moving target with the emergence of newer agents and patient-related risk factors, as well as the rapid evolution of guidelines for the management of chemotherapy-induced nausea and vomiting.

x